TrialCancer science2024

Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.

Tetsuya Mitsudomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.